Transcranial Random Noise Stimulation for the Acute Treatment of Depression: A Randomized Controlled Trial

Area of Science:

• Neuroscience
• Psychiatry
• Medical Devices

Background:

• Transcranial electrical stimulation (TES) shows promise for treating depression.
• Transcranial random noise stimulation (tRNS) may offer enhanced cortical excitatory effects compared to other TES methods.
• Investigating the antidepressant efficacy of tRNS is crucial for potential therapeutic applications.

Purpose of the Study:

• To evaluate the antidepressant efficacy of transcranial random noise stimulation (tRNS).
• To compare the effects of active tRNS versus sham tRNS in participants with depression.
• To assess secondary outcomes including neuroplasticity, neuropsychological function, and safety.

Main Methods:

• A double-blinded, parallel-group randomized-controlled trial was conducted.
• Participants received 20 sessions of either active or sham tRNS over 4 weeks.
• Depression severity was measured using the Montgomery-Asperg Depression Rating Scale.

Main Results:

• Depression severity scores decreased in both active and sham tRNS groups.
• No significant differences were observed between active and sham groups in symptom reduction, response, or remission rates.
• Adverse events like erythema and paresthesia were more frequent in the active tRNS group.

Conclusions:

• The study's findings do not support the use of tRNS with the current parameters for treating depression.
• Further research may be needed to explore optimal parameters or alternative applications of tRNS.
• The safety profile of tRNS requires careful consideration in clinical settings.